Increased Risk of Second Incident Cancer in Patients With CLL Receiving BTK Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors
Leukemia 2020 Jul 23;[EPub Ahead of Print], DA Bond, Y Huang, JL Fisher, AS Ruppert, DH Owen, EM Bertino, KA Rogers, SA Bhat, MR Grever, SM Jaglowski, KJ Maddocks, JC Byrd, JA WoyachFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.